| 301 | NAIINatural Alternatives International Inc |
$142.5M |
-14.5% |
2026 |
| 302 | BEAMBeam Therapeutics Inc. |
$139.7M |
-57.2% |
2025 |
| 303 | NRCNrc Health |
$137.4M |
8.2% |
2025 |
| 304 | RXSTRxSight, Inc. |
$134.5M |
-29.0% |
2025 |
| 305 | AAPGAscentage Pharma Group International |
$134.3M |
-41.3% |
2024 |
| 306 | XTNTXtant Medical Holdings, Inc. |
$133.9M |
3.7% |
2025 |
| 307 | NAGENiagen Bioscience, Inc. |
$129.4M |
13.4% |
2025 |
| 308 | LFCRLifecore Biomedical, Inc. DE |
$128.9M |
-30.0% |
2025 |
| 309 | XNCRXencor Inc |
$125.6M |
-73.2% |
2025 |
| 310 | GLUEMonte Rosa Therapeutics, Inc. |
$123.7M |
-31.2% |
2025 |
| 311 | ATRAAtara Biotherapeutics, Inc. |
$120.8M |
27.1% |
2025 |
| 312 | OMOutset Medical, Inc. |
$119.5M |
-68.3% |
2025 |
| 313 | GYREGyre Therapeutics, Inc. |
$116.6M |
8.5% |
2025 |
| 314 | OSUROrasure Technologies Inc |
$115M |
-59.8% |
2025 |
| 315 | AGENAgenus Inc |
$114.2M |
-0.1% |
2025 |
| 316 | IBRXImmunityBio, Inc. |
$113.3M |
-310.2% |
2025 |
| 317 | ANIKAnika Therapeutics, Inc. |
$112.8M |
-9.6% |
2025 |
| 318 | URGNUroGen Pharma Ltd. |
$109.8M |
-139.8% |
2025 |
| 319 | IPSCCentury Therapeutics, Inc. |
$109.2M |
-8.8% |
2025 |
| 320 | MTEXMannatech Inc |
$108M |
-14.1% |
2025 |
| 321 | MDXHMDxHealth SA |
$107.9M |
-31.1% |
2025 |
| 322 | TBPHTheravance Biopharma, Inc. |
$107.5M |
98.5% |
2025 |
| 323 | ZVRAZevra Therapeutics, Inc. |
$106.5M |
78.2% |
2025 |
| 324 | ZYMEZymeworks Inc. |
$106M |
-76.6% |
2025 |
| 325 | SMTISanara MedTech Inc. |
$103.1M |
-36.4% |
2025 |
| 326 | STROSutro Biopharma, Inc. |
$102.5M |
-186.5% |
2025 |
| 327 | BBNXBeta Bionics, Inc. |
$100.3M |
-73.0% |
2025 |
| 328 | NPCENeuroPace Inc |
$100M |
-21.5% |
2025 |
| 329 | BFLYButterfly Network, Inc. |
$97.6M |
-79.0% |
2025 |
| 330 | BLFSBiolife Solutions Inc |
$96.2M |
-4.8% |
2025 |
| 331 | ISPRIspire Technology Inc. |
$96M |
-34.6% |
2026 |
| 332 | KMTSKestra Medical Technologies, Ltd. |
$95.1M |
-138.4% |
2026 |
| 333 | SIGASiga Technologies Inc |
$94.6M |
24.6% |
2025 |
| 334 | LUNGPulmonx Corp |
$90.5M |
-59.7% |
2025 |
| 335 | VASOVASO Corp |
$89.1M |
1.8% |
2025 |
| 336 | CBLLCeribell, Inc. |
$89.1M |
-60.0% |
2025 |
| 337 | BDSXBiodesix Inc |
$88.5M |
-39.8% |
2025 |
| 338 | CYTKCytokinetics Inc |
$88M |
-891.6% |
2025 |
| 339 | DCTHDelcath Systems, Inc. |
$85.2M |
3.2% |
2025 |
| 340 | FDMT4D Molecular Therapeutics, Inc. |
$85.2M |
-164.4% |
2025 |
| 341 | SPRYARS Pharmaceuticals, Inc. |
$84.3M |
-203.3% |
2025 |
| 342 | NRIXNurix Therapeutics, Inc. |
$84M |
-314.9% |
2025 |
| 343 | IRMDIradimed Corp |
$83.8M |
26.8% |
2025 |
| 344 | ARCTArcturus Therapeutics Holdings Inc. |
$82M |
-80.2% |
2025 |
| 345 | FTLFFitlife Brands, Inc. |
$81.5M |
7.8% |
2025 |
| 346 | MGTXMeiraGTx Holdings plc |
$81.4M |
-140.3% |
2025 |
| 347 | ADCTADC Therapeutics SA |
$81.4M |
-175.3% |
2025 |
| 348 | TELATELA Bio, Inc. |
$80.3M |
-48.4% |
2025 |
| 349 | ETONEton Pharmaceuticals, Inc. |
$80M |
-5.8% |
2025 |
| 350 | PDEXPro Dex Inc |
$77.5M |
17.6% |
2026 |